Mostrar el registro sencillo del ítem

Mortality as an adverse outcome of sarcopenia

dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorVICTORIA EUGENIA ARANGO LOPERAes_MX
dc.creatorPEDRO ARROYO ACEVEDOes_MX
dc.creatorLUIS MIGUEL FRANCISCO GUTIERREZ ROBLEDOes_MX
dc.creatorMARIO ULISES PEREZ ZEPEDAes_MX
dc.creatorMatteo Cesaries_MX
dc.date2013
dc.date.accessioned2021-10-28T17:53:14Z
dc.date.available2021-10-28T17:53:14Z
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17286
dc.descriptionSarcopenia has an important impact in elderly. Recently the European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as the loss of muscle mass plus low muscle strength or low physical performance. Lack of clinical sounding outcomes (ie external validity), is one of the flaws of this algorithm. The aim of our study was to determine the association of sarcopenia and mortality in a group of Mexican elderly. A total of 345 elderly were recruited in Mexico City, and followed up for three years. The EWGSOP algorithm was integrated by: gait speed, grip strength and calf circumference. Other covariates were assessed in order to test the independent association of sarcopenia with mortality. Of the 345 subjects, 53.3% were women; with a mean age of 78.5 (SD 7) years. During the three year follow-up a total of 43 (12.4%) subjects died. Age, cognition, ADL, IADL, health self-perception, ischemic heart disease and sarcopenia were associated in the bivariate analysis with survival. Negative predictive value for sarcopenia regarding mortality was of 90%. Kaplan-Meier curves along with their respective log-rank test were significant for sarcopenia. The components of the final Cox-regression multivariate model were age, ischemic heart disease, ADL and sarcopenia. Adjusted HR for age was 3.24 (CI 95% 1.55–6.78 p 0.002), IHD 5.07 (CI 95% 1.89–13.59 p 0.001), health self-perception 5.07 (CI 95% 1.9–13.6 p 0.001), ADL 0.75 (CI 95% 0.56–0.99 p 0.048) and sarcopenia 2.39 (CI 95% 1.05–5.43 p 0.037).es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherSpringer Verlag & Serdi-Editionses_MX
dc.relationhttps://link.springer.com/article/10.1007%2Fs12603-012-0434-0es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceJournal of Nutrition, Health an Aging (1760-4788) Vol. 17 (2012)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectEnvejecimientoes_MX
dc.subjectAtrofia musculares_MX
dc.subjectSarcopeniaes_MX
dc.subjectNutrición en personas mayoreses_MX
dc.subjectGeriatricses_MX
dc.subjectAginges_MX
dc.subjectMuscular atrophyes_MX
dc.subjectNutrition in elderlyes_MX
dc.titleMortality as an adverse outcome of sarcopeniaes_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idAALV680413MNERPC04es_MX
dc.creator.idAOAP390626HDFRCD02es_MX
dc.creator.idGURL571005HDFTBS14es_MX
dc.creator.idPEZM760111HDFRPR07es_MX
dc.creator.id0000-0002-0348-3664es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercvues_MX


Ficheros en el ítem

Thumbnail
Nombre:
Journal of Nutrition, Health an ...
Tamaño:
140.2Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem